Rocket Pharmaceuticals (RCKT) Treasury Shares (2014 - 2023)

Rocket Pharmaceuticals has reported Treasury Shares for 5 years, with the latest figure at $47000.0 in Q2 2023.

• Quarterly Treasury Shares changed N/A year-over-year to $47000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $47000.0 (changed N/A YoY) and the FY2022 annual result came in at $47000.0, changed N/A from the prior year.
• Treasury Shares steadied at $47000.0 in Q2 2023 per RCKT's latest filing, from $47000.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $7.7 million in Q1 2026 and troughed at $457709.0 in Q1 2022.
• A 5-year average of $3.7 million and a median of $4.0 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2019 and 2020: Treasury Shares plunged 92.07% in 2019, then slumped 77.91% in 2020.
• Over 4 years, Treasury Shares stood at $53000.0 in 2019, then soared by 43.4% to $76000.0 in 2020, then slumped by 38.16% to $47000.0 in 2022, then changed by 0.0% to $47000.0 in 2023.
• According to Business Quant data, Treasury Shares over the past three periods registered $47000.0, $47000.0, and $47000.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.